|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors显示文摘 | Schoffski P | 2004 | Anticancer Drugs2004，15，： | 1 |
| 2 | Tissue factor and thrombomodulin levels,correlated with stage of cirrhosis in patients with liver disease显示文摘 | Tacke F Schoffski P Trautwein C | 2001 | Blood Coagul Fibrinolysis2001，12，7： | 1 |
| 3 | Thrombopoietin serum levels are elevated in patients with hepatitis B/C infection compared to other causes of chronic liver disease 显示文摘 | SCHOFFSKI P TACKE F TRAUTWEIN C | 2002 | Liver2002，22，2： | 1 |
| 4 | Activity of eribu- lin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes 显示文摘 | Schoffski P Ray-Coquard IL Cioffi A | 2011 | Lancet On- col2011，12，11： | 1 |
| 5 | Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma显示文摘 | Lutz M P Schoffski P | 2006 | Ann Oncol2006，17，3： | 1 |
| 6 | Activ!ty of eribulin mesylate (E7389) in patients with soft tissue sarcoma (STS): Phase II studies of the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC 62052) 显示文摘 | Schoffski P Ray - Coquard IL Cioffi A | 2010 | J Clin Oncol2010，28，10： | 1 |
| 7 | The modulated oral fluoropyrimidine prodrug S- 1 , and its use in gastrointestinal cancer and other solid tumors 显示文摘 | SCHOFFSKI P | 2004 | Anticancer Drugs2004，15，2： | 1 |
| 8 | A phase I pharmacokinetic (PK) and molecular pharm-acodynamic(PD) study of the combination of two anti-EGFR therapies,the monoclonal antibody (MAb) cetuximab (C) and the tyrosine kinase inhibitor (TKI) gefitinib (G),in patients (pts) with advanced colorectal (CRC),head and neck (HNC) and non-small cell lung cancer (NSCLC)显示文摘 | Baselga J Schoffski P Rojo F | 2006 | ASCO Meeting Abstracts2006，24，18： | 1 |
| 9 | Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluoreuracil and leucovorin:a randomised crossover trial in advanced colorectal cancer 显示文摘 | Borner MM Schoffski P de Wit R | 2002 | Eur J Cancer2002，38，3： | 1 |
| 10 | EORTC Early Clinical Studies Group early phase Ⅱ trial of S-1 in pa- tients with advanced or metastatic colorectal cancer显示文摘 | Van den Brande J SchOffski P Schellens JH | 2003 | Br J Cancer2003，88，5： | 1 |
| 11 | Tissue factor and thrombomodu lin levels are correlated with stage of cirrhosis in patients with liver dis- ease显示文摘 | T Acke F Schoffski P Trautwein C | 2001 | Blood Coagul Fibrinolysis2001，12，7： | 1 |
| 12 | Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion:results of a randomized trial in patients with advanced colorectal cancer显示文摘 | Kohne CH Schoffski P Wilke H | | 0，，2： | 1 |
| 13 | Cetuximab and ironotecan /5-fluorouracil/folinic acid is a safe combination for the first(-)line treatment of patients with epidermal growth foctor receptor expressing metastatic colorectal carcinoma显示文摘 | Folprecht G Lutz M P Schoffski P | 2005 | Ann Oncol2005，22，： | 1 |
| 14 | EORTCEarly Clinical Studies Group early phaseⅡtrial of S-1 in patientswith advanced or metastatic colorectal cancer显示文摘 | Van den Brande J Schoffski P Schellens JH | 2003 | Br J Cancer2003，88，： | 1 |
| 15 | Plasma P-selectin levels are elevated in patients with chronic liver disease 显示文摘 | Tacke F Schoffski P Trautwein C | 2003 | Blood Coagul Fibrinolysis2003，，4： | 1 |
| 16 | The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors 显示文摘 | Schoffski P | 2004 | Anticancer Drugs2004，15，2： | 1 |
| 17 | Plasma P-selectin levels are elevated in patients with chronic liver disease显示文摘 | Tacke F Schoffski P Trautwein C | 2003 | Blood Coagul Fibrinolysis2003，14，4： | 1 |
| 18 | Cetuximab andirinotecan/5-fluorouracil/folinic acid is a safe combination for the firstline treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma 显示文摘 | Folprecht G Lutz MP Schoffski P | 2006 | Ann Oncol2006，17，3： | 1 |
| 19 | Complete longitudinalanalyses of the randomized, placebo-controlled, phase Ill trial of sunitinib in patients with gastrointestinal stromal tumor following imatinib failure显示文摘 | Demetri GD Garrett CR Schoffski P | 2012 | Clin Cancer Res2012，18，11： | 1 |
| 20 | Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metaastatic squamous cell carcinoma of the head and neck 显示文摘 | Schoffski P Catimel G Planting AS | 1999 | Ann Oncol1999，10，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员